Pamela P. Palmer
2022
In 2022, Pamela P. Palmer earned a total compensation of $822.4K as Chief Medical Officer at AcelRx Pharmaceuticals, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,096 |
|---|---|
| Option Awards | $73,462 |
| Salary | $526,458 |
| Stock Awards | $49,184 |
| Other | $12,200 |
| Total | $822,400 |
Palmer received $526.5K in salary, accounting for 64% of the total pay in 2022.
Palmer also received $161.1K in non-equity incentive plan, $73.5K in option awards, $49.2K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Pamela P. Palmer's compensation ranked 3,443rd out of 5,760 executives tracked by ExecPay. In other words, Palmer earned more than 40.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,443 out of 5,760 | 40th |
Division Manufacturing | 1,947 out of 3,136 | 38th |
Major group Chemicals And Allied Products | 931 out of 1,422 | 35th |
Industry group Drugs | 870 out of 1,323 | 34th |
Industry Pharmaceutical Preparations | 636 out of 969 | 34th |
Source: SEC filing on August 28, 2023.
Palmer's colleagues
We found two more compensation records of executives who worked with Pamela P. Palmer at AcelRx Pharmaceuticals in 2022.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019